Medicine

Even today, women remain underrepresented in science and in research-driven industry. At Fraunhofer IZM, women account for 29.3 % of all employees, with a greater proportion of women in non-scientific (50 %) than in science jobs (23.8 %).* To counter…

Chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) are lung diseases that cause high mortality. The EU-wide REMEDIA project develops technologies for measuring environmental influences that have an impact on these diseases. Four Fraunhofer Institutes are part of the…

Non-invasive blood glucose monitoring systems are one of the hottest topics in current medical technology. That is one of the reasons why the FMD space, which Fraunhofer IZM is a part of, endowed the idea of the start-up Quantune Technologies…

The number of people infected with the novel SARS-CoV-2 virus is increasing at an alarming rate around the globe. According to data published by Johns Hopkins University, the virus has already affected 180 countries and been detected in the blood…

Driven by curiosity and the spirit of discovery, Adam Rumjahn founded his own start-up: Orion AM. His vision is to use industrial additive manufacturing for advanced applications, using aerospace-grade polymers. 3D printing with these super-plastics is a revolutionary prospect for…

What would it be like if we no longer had to travel far for certain medicinal plants, cut down rainforests, and carry out time-consuming searches? We interviewed Dr. Rafael Jordan about a project that can save lives, protect the environment,…